Pfizer Inc.PFE

Is PFE cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$27.72+0.00 (+0.00%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$158B
Large-cap
-18%
2016 — today
10-Year Price
-12%
2016 — today
52-Week Range
$23.60$29.02
Current $27.72· 76%

Pfizer researches, develops, and distributes biopharmaceuticals and vaccines globally. Its portfolio spans cardiovascular and women’s health (Premarin, Eliquis), oncology (Ibrance, Xtandi), and immunology (Xeljanz, Inflectra). The firm provides sterile injectables, anti-infectives, and COVID-19 treatments like Paxlovid. Its vaccine division includes Comirnaty and the Prevnar family. Pfizer also develops rare disease therapies (Vyndaqel, BeneFIX), operates a contract manufacturing unit, and partners with BioNTech and BMS.

Similar companies

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
36.6
Near historic high
Near historic highs — last 10 years
Sector median 25.0above sector
P/B ratio
1.8
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.5below sector
EV / EBITDA
17.4
Historically pricey
Historically pricey — last 10 years
Sector median 15.4above sector
Dividend Yield
6.2%
Historically high
Historically high relative to the last 10 years
Sector median 1.7%above sector
FCF Yield
7.0%
Above average
Above the 10-year average
Sector median -10.1%above sector
Free · No credit card needed

Get alerted when PFE is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.